The Association Between Neutrophil/Lymphocyte Ratio and Disease Activity in Rheumatoid Arthritis and Ankylosing Spondylitis

Journal of Clinical Laboratory Analysis

Volumn 30, Issue 5, 2016, Pages 597-601

  Mercan, Ridvan ^a   Bitik, Berivan ^a   Tufan, Abdurrahman ^a   Bozbulut, Utku Burak ^a   Atas, Nuh ^a   Ozturk, Mehmet Akif ^a   Haznedaroglu, Seminur ^a   Goker, Berna ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

ankylosing spondylitis; disease activity, neutrophil; neutrophil to lymphocyte ratio; rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; CONTROLLED STUDY; DAS28; DISEASE ACTIVITY; DISEASE ACTIVITY SCORE; DISEASE ASSOCIATION; DISEASE DURATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; NEUTROPHIL LYMPHOCYTE RATIO; REMISSION; RHEUMATOID ARTHRITIS;

EID: 84989231107     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.21908     Document Type: Article

References (32)

1. Zochling J, Braun J. Mortality in rheumatoid arthritis and ankylosing spondylitis. Clin Exp Rheumatol 2009;27:127–130.
2. Hobbs KF, Cohen MD. Rheumatoid arthritis disease measurement: A new old idea. Rheumatology (Oxford) 2012;51(Suppl 6):21–27.
3. Colglazier CL, Sutej PG. Laboratory testing in the rheumatic diseases: A practical review. South Med J 2005;98:185–191.
4. Kavanaugh A. The role of the laboratory in the evaluation of rheumatic diseases. Clin Cornerstone 1999;2(2):11–25.
5. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340(6):448–454.
6. Kisacik B, Tufan A, Kalyoncu U, et al. Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis. Joint Bone Spine 2008;75(3):291–294.
7. Ruggiero C, Metter EJ, Cherubini A, et al. White blood cell count and mortality in the Baltimore Longitudinal Study of Aging. J Am Coll Cardiol 2007;49(18):1841–1850.
8. Bender BS, Nagel JE, Adler WH, Andres R. Absolute peripheral blood lymphocyte count and subsequent mortality of elderly men. The Baltimore Longitudinal Study of Aging. J Am Geriatr Soc 1986;34(9):649–654.
9. Kouri VP, Olkkonen J, Ainola M, et al. Neutrophils produce interleukin-17B in rheumatoid synovial tissue. Rheumatology (Oxford) 2014;53(1):39–47.
10. Cascao R, Rosario HS, Souto-Carneiro MM, Fonseca JE. Neutrophils in rheumatoid arthritis: More than simple final effectors. Autoimmun Rev 2010;9(8):531–535.
11. McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011;365(23):2205–2219.
12. Torun S, Tunc BD, Suvak B, et al. Assessment of neutrophil-lymphocyte ratio in ulcerative colitis: A promising marker in predicting disease severity. Clin Res Hepatol Gastroenterol 2012;36(5):491–497.
13. Ahsen A, Ulu MS, Yuksel S, et al. As a new inflammatory marker for familial Mediterranean fever: Neutrophil-to-lymphocyte ratio. Inflammation 2013;36(6):1357–1362.
14. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31(3):315–324.
15. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27(4):361–368.
16. Prevoo ML, van ’t Hof MA, Kuper HH, et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38(1):44–48.
17. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: The Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21(12):2286–2291.
18. Tamhane UU, Aneja S, Montgomery D, Rogers EK, Eagle KA, Gurm HS. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol 2008;102(6):653–657.
19. Ozturk ZA, Kuyumcu ME, Yesil Y, et al. Is there a link between neutrophil-lymphocyte ratio and microvascular complications in geriatric diabetic patients? J Endocrinol Invest 2013;36(8):593–599.
20. Kuyumcu ME, Yesil Y, Ozturk ZA, et al. The evaluation of neutrophil-lymphocyte ratio in Alzheimer's disease. Dement Geriatr Cogn Disord 2012;34(2):69–74.
21. Fowler AJ, Agha RA. Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography—The growing versatility of NLR. Atherosclerosis 2013;228(1):44–45.
22. Biyik M, Ucar R, Solak Y, et al. Blood neutrophil-to-lymphocyte ratio independently predicts survival in patients with liver cirrhosis. Eur J Gastroenterol Hepatol 2013;25(4):435–441.
23. Proctor MJ, McMillan DC, Morrison DS, Fletcher CD, Horgan PG, Clarke SJ. A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer. Br J Cancer 2012;107(4):695–699.
24. Strydom N, Rankin SM. Regulation of circulating neutrophil numbers under homeostasis and in disease. J Innate Immun 2013;5(4):304–314.
25. Krstic A, Mojsilovic S, Jovcic G, Bugarski D. The potential of interleukin-17 to mediate hematopoietic response. Immunol Res 2012;52(1–2):34–41.
26. Smith E, Zarbock A, Stark MA, et al. IL-23 is required for neutrophil homeostasis in normal and neutrophilic mice. J Immunol 2007;179(12):8274–8279.
27. Kantola T, Klintrup K, Vayrynen JP, et al. Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma. Br J Cancer 2012;107(10):1729–1736.
28. Dougados M, Baeten D. Spondyloarthritis. Lancet 2011;377(9783):2127–2137.
29. Symmons DP, Farr M, Salmon M, Bacon PA. Lymphopenia in rheumatoid arthritis. J R Soc Med 1989;82(8):462–463.
30. Sherlock JP, Buckley CD, Cua DJ. The critical role of interleukin-23 in spondyloarthropathy. Mol Immunol 2014;57(1):38–43.
31. Fu H, Qin B, Hu Z, et al. Neutrophil- and platelet-to-lymphocyte ratios are correlatedwith disease activity in rheumatoid arthritis. Clin Lab 2015;61(3–4):269–273.
32. Uslu AU, Kucuk A, Sahin A, et al. Two new inflammatory markers associated with disease activity score-28 in patients with rheumatoid arthritis: Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio. Int J Rheum Dis PMID:25900081 2015;18(7):731–735.